AR ‐V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration‐resistant prostate cancer patients
The Prostate, EarlyView.
Source: The Prostate - Category: Urology & Nephrology Source Type: research
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Prostate Cancer | Urology & Nephrology